Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ardelyx, Inc. (ARDX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ardelyx, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1437402.
Total stock buying since 2015: $687,338,374.
Total stock sales since 2015: $44,793,715.
Total stock option exercises since 2015: $2,084,425.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 333,333 | $1,946,331 | 178,604 | $1,109,455 | 70,833 | $70,124 |
| 2025 | 1,158,106 | $4,784,370 | 576,495 | $3,036,935 | 254,166 | $207,621 |
| 2024 | 215,868 | $996,662 | 1,505,564 | $11,147,369 | 693,888 | $1,224,644 |
| 2023 | 0 | $0 | 539,979 | $2,731,579 | 108,333 | $188,248 |
| 2022 | 2,889,000 | $5,037,201 | 629,644 | $566,452 | 0 | $0 |
| 2021 | 0 | $0 | 5,890,134 | $7,577,251 | 285,392 | $154,111 |
| 2020 | 315,644 | $1,998,216 | 680,999 | $4,289,107 | 78,123 | $136,452 |
| 2019 | 66 | $495 | 97,167 | $295,257 | 30,000 | $45,000 |
| 2018 | 10,000 | $40,000 | 25,779 | $73,294 | 0 | $0 |
| 2017 | 0 | $0 | 26,700 | $263,494 | 6,000 | $3,240 |
| 2016 | 39,188,162 | $361,783,231 | 27,045 | $335,943 | 21,000 | $20,905 |
| 2015 | 29,033,691 | $310,751,868 | 554,269 | $13,367,579 | 51,727 | $34,080 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-21 | Renz Justin A (Chief Financial Officer) | Sale | 2,884 | 3.55 | 10,243 |
| 2023-08-21 | Raab Michael (President & CEO) | Sale | 11,419 | 3.55 | 40,560 |
| 2023-08-21 | Grammer Elizabeth A (See Remarks) | Sale | 2,392 | 3.55 | 8,496 |
| 2023-06-27 | Williams Laura A (Chief Medical Officer) | Sale | 25,000 | 3.35 | 83,625 |
| 2023-06-23 | Blanks Robert (See Remarks) | Sale | 33,333 | 3.63 | 121,032 |
| 2023-06-23 | Blanks Robert (See Remarks) | Option Ex | 33,333 | 3.42 | 113,998 |
| 2023-05-23 | Felsch Robert Ora (See Remarks) | Sale | 1,046 | 3.65 | 3,821 |
| 2023-05-23 | Williams Laura A (Chief Medical Officer) | Sale | 2,583 | 3.65 | 9,435 |
| 2023-05-23 | Blanks Robert (See Remarks) | Sale | 2,835 | 3.65 | 10,356 |
| 2023-05-23 | Rodriguez Susan (Chief Commercial Officer) | Sale | 4,711 | 3.65 | 17,209 |
| 2023-05-23 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,769 | 3.65 | 13,768 |
| 2023-05-23 | Renz Justin A (Chief Financial Officer) | Sale | 2,873 | 3.65 | 10,495 |
| 2023-05-23 | Raab Michael (President & CEO) | Sale | 11,357 | 3.65 | 41,487 |
| 2023-05-23 | Grammer Elizabeth A (See Remarks) | Sale | 2,384 | 3.65 | 8,708 |
| 2023-03-29 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,000 | 4.63 | 13,886 |
| 2023-02-21 | Felsch Robert Ora (See Remarks) | Sale | 3,214 | 3.00 | 9,645 |
| 2023-02-21 | Williams Laura A (Chief Medical Officer) | Sale | 3,187 | 3.00 | 9,564 |
| 2023-02-21 | Blanks Robert (See Remarks) | Sale | 3,394 | 3.00 | 10,185 |
| 2023-02-21 | Rodriguez Susan (Chief Commercial Officer) | Sale | 5,586 | 3.00 | 16,763 |
| 2023-02-21 | Rosenbaum David P. (Chief Development Officer) | Sale | 4,508 | 3.00 | 13,528 |
| 2023-02-21 | Raab Michael (President & CEO) | Sale | 13,449 | 3.00 | 40,360 |
| 2022-11-22 | Williams Laura A (Chief Medical Officer) | Sale | 2,482 | 1.95 | 4,826 |
| 2022-11-22 | Blanks Robert (See Remarks) | Sale | 2,928 | 1.94 | 5,692 |
| 2022-11-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 6,912 | 1.95 | 13,442 |
| 2022-11-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,896 | 1.95 | 7,580 |
| 2022-11-22 | Renz Justin A (Chief Financial Officer) | Sale | 3,008 | 1.95 | 5,850 |
| 2022-11-22 | Raab Michael (President & CEO) | Sale | 12,438 | 1.94 | 24,178 |
| 2022-11-22 | Grammer Elizabeth A (See Remarks) | Sale | 2,484 | 1.95 | 4,830 |
| 2022-11-17 | Mott David M | Buy | 1,701,000 | 1.76 | 3,002,265 |
| 2022-10-05 | Blanks Robert (See Remarks) | Sale | 100,000 | 1.50 | 150,000 |
| 2022-09-01 | Rosenbaum David P. (Chief Development Officer) | Sale | 6,000 | .92 | 5,520 |
| 2022-08-31 | Felsch Robert Ora (See Remarks) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Williams Laura A (Chief Medical Officer) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Rosenbaum David P. (Chief Development Officer) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Renz Justin A (Chief Financial Officer) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Raab Michael (President & CEO) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Grammer Elizabeth A (See Remarks) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-22 | Williams Laura A (Chief Medical Officer) | Sale | 1,276 | .98 | 1,253 |
| 2022-08-22 | Blanks Robert (See Remarks) | Sale | 1,458 | .98 | 1,431 |
| 2022-08-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 3,420 | .98 | 3,358 |
| 2022-08-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 1,955 | .98 | 1,919 |
| 2022-08-22 | Renz Justin A (Chief Financial Officer) | Sale | 1,498 | .98 | 1,469 |
| 2022-08-22 | Raab Michael (President & CEO) | Sale | 6,146 | .98 | 6,029 |
| 2022-08-22 | Grammer Elizabeth A (See Remarks) | Sale | 1,236 | .98 | 1,212 |
| 2022-07-26 | Blanks Robert (See Remarks) | Sale | 5,188 | .67 | 3,475 |
| 2022-06-06 | Blanks Robert (See Remarks) | Sale | 73,312 | .64 | 47,139 |
| 2022-06-06 | Rodriguez Susan (Chief Commercial Officer) | Sale | 43,920 | .64 | 28,240 |
| 2022-06-06 | Rosenbaum David P. (Chief Development Officer) | Sale | 61,640 | .64 | 39,634 |
| 2022-06-06 | Renz Justin A (Chief Financial Officer) | Sale | 73,312 | .64 | 47,139 |
| 2022-06-06 | Raab Michael (President & CEO) | Sale | 103,624 | .64 | 66,630 |
| 2022-06-06 | Grammer Elizabeth A (See Remarks) | Sale | 60,821 | .64 | 39,107 |
| 2022-05-20 | Blanks Robert (See Remarks) | Sale | 1,489 | .67 | 999 |
| 2022-05-20 | Rodriguez Susan (Chief Commercial Officer) | Sale | 3,425 | .67 | 2,298 |
| 2022-05-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 2,013 | .67 | 1,350 |
| 2022-05-20 | Renz Justin A (Chief Financial Officer) | Sale | 1,528 | .67 | 1,025 |
| 2022-05-20 | Raab Michael (President & CEO) | Sale | 12,248 | .67 | 8,218 |
| 2022-05-20 | Grammer Elizabeth A (See Remarks) | Sale | 2,526 | .67 | 1,694 |
| 2021-12-15 | Baskett Forest (10% Owner) | Sale | 1,211,352 | 1.14 | 1,384,575 |
| 2021-12-15 | Sandell Scott D (10% Owner) | Sale | 1,211,352 | 1.14 | 1,384,575 |
| 2021-12-14 | Baskett Forest (10% Owner) | Sale | 1,000,735 | 1.24 | 1,244,914 |
| 2021-12-14 | Sandell Scott D (10% Owner) | Sale | 1,000,735 | 1.24 | 1,244,914 |
| 2021-12-09 | Baskett Forest (10% Owner) | Sale | 669,483 | 1.51 | 1,012,927 |
| 2021-12-09 | Sandell Scott D (10% Owner) | Sale | 669,483 | 1.51 | 1,012,927 |
| 2021-11-22 | Blanks Robert (See Remarks) | Sale | 643 | .99 | 637 |
| 2021-11-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 643 | .99 | 637 |
| 2021-11-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 827 | .99 | 820 |
| 2021-11-22 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 5,754 | .98 | 5,661 |
| 2021-11-22 | Renz Justin A (Chief Financial Officer) | Sale | 643 | .99 | 637 |
| 2021-11-22 | Raab Michael (President & CEO) | Sale | 2,607 | .99 | 2,586 |
| 2021-11-22 | Grammer Elizabeth A (See Remarks) | Sale | 537 | .99 | 532 |
| 2021-11-15 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 5,000 | 1.13 | 5,649 |
| 2021-11-12 | Grammer Elizabeth A (See Remarks) | Sale | 77,432 | 1.12 | 87,111 |
| 2021-11-08 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 2,166 | 1.18 | 2,555 |
| 2021-08-20 | Blanks Robert (See Remarks) | Sale | 631 | 1.32 | 832 |
| 2021-08-20 | Rodriguez Susan (Chief Commercial Officer) | Sale | 630 | 1.32 | 831 |
| 2021-08-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 807 | 1.32 | 1,065 |
| 2021-08-20 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 741 | 1.32 | 978 |
| 2021-08-20 | Renz Justin A (Chief Financial Officer) | Sale | 631 | 1.32 | 832 |
| 2021-08-20 | Raab Michael (President & CEO) | Sale | 2,573 | 1.32 | 3,396 |
| 2021-08-20 | Grammer Elizabeth A (See Remarks) | Sale | 526 | 1.32 | 694 |
| 2021-08-03 | Jacobs Jeffrey W (Chief Scientific Officer) | Option Ex | 10,000 | .54 | 5,400 |
| 2021-08-03 | Raab Michael (President & CEO) | Option Ex | 267,892 | .54 | 144,661 |
| 2021-06-15 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 7,500 | 7.29 | 54,660 |
| 2021-06-15 | Jacobs Jeffrey W (Chief Scientific Officer) | Option Ex | 7,500 | .54 | 4,050 |
| 2021-05-28 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,062 | 7.22 | 22,098 |
| 2021-05-20 | Blanks Robert (See Remarks) | Sale | 612 | 7.09 | 4,337 |
| 2021-05-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 769 | 7.09 | 5,450 |
| 2021-05-20 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 721 | 7.09 | 5,110 |
| 2021-05-20 | Renz Justin A (Chief Financial Officer) | Sale | 612 | 7.09 | 4,337 |
| 2021-04-06 | Blanks Robert (See Remarks) | Sale | 5,163 | 8.00 | 41,304 |
| 2021-02-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 611 | 6.88 | 4,205 |
| 2021-02-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 805 | 6.88 | 5,540 |
| 2021-02-22 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 702 | 6.88 | 4,831 |
| 2021-02-22 | Renz Justin A (Chief Financial Officer) | Sale | 608 | 6.88 | 4,184 |
| 2021-02-22 | Raab Michael (President & CEO) | Sale | 2,534 | 6.88 | 17,441 |
| 2021-02-22 | Grammer Elizabeth A (See Remarks) | Sale | 504 | 6.88 | 3,469 |
| 2020-12-21 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 3,949 | 6.88 | 27,153 |
| 2020-12-14 | Grammer Elizabeth A (See Remarks) | Sale | 41,000 | 7.30 | 299,300 |
| 2020-12-14 | Grammer Elizabeth A (See Remarks) | Option Ex | 41,000 | 2.32 | 95,120 |
| 2020-12-11 | Grammer Elizabeth A (See Remarks) | Sale | 1,000 | 7.30 | 7,300 |
| 2020-12-11 | Grammer Elizabeth A (See Remarks) | Option Ex | 1,000 | 2.32 | 2,320 |
| 2020-12-10 | Mott David M | Buy | 170,000 | 5.89 | 1,000,789 |
| 2020-09-16 | Rodriguez Susan (Chief Commercial Officer) | Sale | 6,087 | 6.11 | 37,167 |
| 2020-09-16 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 10,000 | 6.05 | 60,500 |
| 2020-09-15 | Blanks Robert (See Remarks) | Sale | 34,685 | 5.45 | 189,171 |
| 2020-09-15 | Rosenbaum David P. (Chief Development Officer) | Sale | 38,126 | 5.52 | 210,341 |
| 2020-09-15 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 40,804 | 5.53 | 225,605 |
| 2020-09-15 | Renz Justin A (Chief Financial Officer) | Sale | 3,714 | 5.49 | 20,371 |
| 2020-09-15 | Raab Michael (President & CEO) | Sale | 106,337 | 5.61 | 596,337 |
| 2020-09-15 | Grammer Elizabeth A (See Remarks) | Sale | 28,810 | 5.37 | 154,565 |
| 2020-09-01 | Blanks Robert (See Remarks) | Sale | 2,049 | 5.58 | 11,425 |
| 2020-07-02 | Raab Michael (President & CEO) | Sale | 23,128 | 7.01 | 162,127 |
| 2020-06-25 | Mott David M | Buy | 68,373 | 6.96 | 476,012 |
| 2020-06-24 | Mott David M | Buy | 72,598 | 6.75 | 489,891 |
| 2020-06-22 | Mott David M | Buy | 4,673 | 6.75 | 31,524 |
| 2020-06-15 | Baskett Forest (10% Owner) | Sale | 43 | 6.37 | 273 |
| 2020-06-15 | Sandell Scott D (10% Owner) | Sale | 43 | 6.37 | 273 |
| 2020-06-12 | Baskett Forest (10% Owner) | Sale | 44,992 | 6.42 | 288,668 |
| 2020-06-12 | Sandell Scott D (10% Owner) | Sale | 44,992 | 6.42 | 288,668 |
| 2020-06-11 | Baskett Forest (10% Owner) | Sale | 67,891 | 6.36 | 431,515 |
| 2020-06-11 | Sandell Scott D (10% Owner) | Sale | 44,991 | 6.32 | 284,478 |
| 2020-06-01 | Raab Michael (President & CEO) | Sale | 23,128 | 7.33 | 169,643 |
| 2020-05-05 | Raab Michael (President & CEO) | Sale | 4,486 | 7.03 | 31,536 |
| 2020-05-04 | Raab Michael (President & CEO) | Sale | 15,941 | 7.01 | 111,682 |
| 2020-04-27 | Grammer Elizabeth A (See Remarks) | Sale | 17,824 | 7.50 | 133,680 |
| 2020-04-17 | Raab Michael (President & CEO) | Sale | 9,428 | 7.02 | 66,165 |
| 2020-04-16 | Raab Michael (President & CEO) | Sale | 10,500 | 7.01 | 73,647 |
| 2020-04-15 | Raab Michael (President & CEO) | Sale | 500 | 7.03 | 3,515 |
| 2020-03-02 | Raab Michael (President & CEO) | Sale | 31,551 | 7.01 | 221,077 |
| 2020-03-02 | Raab Michael (President & CEO) | Option Ex | 11,123 | 1.08 | 12,012 |
| 2020-02-05 | Raab Michael (President & CEO) | Sale | 25,000 | 7.32 | 182,925 |
| 2020-02-05 | Raab Michael (President & CEO) | Option Ex | 25,000 | 1.08 | 27,000 |
| 2019-12-30 | Grammer Elizabeth A (EVP, General Counsel) | Buy | 66 | 7.51 | 495 |
| 2019-12-03 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 5,000 | 8.00 | 40,000 |
| 2019-12-03 | Grammer Elizabeth A (EVP, General Counsel) | Option Ex | 5,000 | 3.42 | 17,100 |
| 2019-11-19 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 5,000 | 7.00 | 35,000 |
| 2019-11-19 | Grammer Elizabeth A (EVP, General Counsel) | Option Ex | 5,000 | 3.42 | 17,100 |
| 2019-10-07 | Kaufmann Mark (Chief Financial Officer) | Sale | 20,000 | 4.56 | 91,199 |
| 2019-10-07 | Kaufmann Mark (Chief Financial Officer) | Option Ex | 20,000 | .54 | 10,800 |
| 2019-08-22 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 948 | 3.50 | 3,318 |
| 2019-08-21 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 4,052 | 3.50 | 14,182 |
| 2019-08-19 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 5,874 | .00 | 0 |
| 2019-06-04 | Rosenbaum David P. (Chief Development Officer) | Sale | 2,856 | 2.54 | 7,257 |
| 2019-06-04 | Kaufmann Mark (Chief Financial Officer) | Sale | 3,357 | 2.55 | 8,550 |
| 2019-06-04 | Raab Michael (President & CEO) | Sale | 10,054 | 2.54 | 25,547 |
| 2019-06-04 | Grammer Elizabeth A (SVP, General Counsel) | Sale | 2,520 | 2.54 | 6,403 |
| 2019-01-02 | Rosenbaum David P. (Chief Development Officer) | Sale | 6,386 | 1.70 | 10,868 |
| 2019-01-02 | Kaufmann Mark (Chief Financial Officer) | Sale | 6,556 | 1.70 | 11,151 |
| 2019-01-02 | Raab Michael (President & CEO) | Sale | 19,644 | 1.70 | 33,414 |
| 2019-01-02 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 4,920 | 1.70 | 8,368 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ardelyx, Inc. (symbol ARDX, CIK number 1437402) see the Securities and Exchange Commission (SEC) website.